-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
- Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $13.3M, a 6690% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)